Legal & General Group PLC Opko Health, Inc. Transaction History

Legal & General Group PLC

  • $390 Billion
  • Q2 2025

A detailed history of Legal & General Group PLC transactions in Opko Health, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 355,682 shares of OPK stock, worth $483,727. This represents 0.0% of its overall portfolio holdings.

Number of Shares
355,682
Previous 350,098 1.59%
Holding current value
$483,727
Previous $581,000 19.28%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$1.24 - $1.66 $6,924 - $9,269
5,584 Added 1.59%
355,682 $469,000
Q1 2025

May 15, 2025
SELL
$1.45 - $1.94 $29,493 - $39,459
-20,340 Reduced 5.49%
350,098 $581,000
Q4 2024

Feb 13, 2025
SELL
$1.4 - $1.64 $105,249 - $123,291
-75,178 Reduced 16.87%
370,438 $544,000
Q3 2024

Feb 28, 2025
BUY
$1.21 - $1.68 $24,037 - $33,374
19,866 Added 5.36%
390,304 $581,000
Q3 2024

Nov 14, 2024
SELL
$1.21 - $1.68 $27,585 - $38,300
-22,798 Reduced 4.87%
445,616 $663,000
Q2 2024

May 29, 2025
SELL
$1.21 - $1.42 $6,655 - $7,810
-5,500 Reduced 1.31%
413,102 $516,000
Q2 2024

Aug 14, 2024
BUY
$1.21 - $1.42 $60,272 - $70,733
49,812 Added 11.9%
468,414 $585,000
Q1 2024

May 29, 2025
BUY
$0.87 - $1.57 $59,598 - $107,551
68,504 Added 19.57%
418,602 $502,000
Q4 2023

May 29, 2025
BUY
$1.23 - $1.63 $84,259 - $111,661
68,504 Added 19.57%
418,602 $632,000
Q3 2023

Nov 14, 2023
SELL
$1.5 - $2.17 $6,313 - $9,133
-4,209 Reduced 1.0%
418,602 $669,000
Q2 2023

Aug 14, 2023
SELL
$1.37 - $2.17 $2,181 - $3,454
-1,592 Reduced 0.38%
422,811 $917,000
Q1 2023

May 15, 2023
BUY
$1.06 - $1.61 $26,953 - $40,939
25,428 Added 6.37%
424,403 $619,000
Q4 2022

Feb 14, 2023
BUY
$1.05 - $2.01 $23,763 - $45,490
22,632 Added 6.01%
398,975 $498,000
Q3 2022

Nov 14, 2022
BUY
$1.81 - $2.81 $52,748 - $81,891
29,143 Added 8.39%
376,343 $712,000
Q2 2022

Aug 22, 2022
SELL
$2.33 - $3.61 $7,118 - $11,028
-3,055 Reduced 0.87%
347,200 $878,000
Q1 2022

May 16, 2022
BUY
$2.87 - $4.93 $19,274 - $33,109
6,716 Added 1.95%
350,255 $1.21 Million
Q4 2021

Feb 14, 2022
SELL
$3.52 - $5.15 $13,492 - $19,739
-3,833 Reduced 1.1%
343,539 $1.65 Million
Q3 2021

Nov 15, 2021
BUY
$3.44 - $4.24 $311,326 - $383,728
90,502 Added 35.23%
347,372 $1.27 Million
Q2 2021

Aug 12, 2021
BUY
$3.33 - $4.55 $15,144 - $20,693
4,548 Added 1.8%
256,870 $1.04 Million
Q1 2021

May 17, 2021
BUY
$4.19 - $5.99 $31,885 - $45,583
7,610 Added 3.11%
252,322 $1.08 Million
Q4 2020

Feb 12, 2021
SELL
$3.27 - $4.87 $155,200 - $231,139
-47,462 Reduced 16.24%
244,712 $966,000
Q3 2020

Nov 13, 2020
BUY
$2.99 - $5.96 $71,410 - $142,342
23,883 Added 8.9%
292,174 $1.08 Million
Q2 2020

Aug 14, 2020
BUY
$1.15 - $3.41 $15,435 - $45,769
13,422 Added 5.27%
268,291 $915,000
Q1 2020

May 14, 2020
SELL
$1.34 - $2.32 $20,835 - $36,073
-15,549 Reduced 5.75%
254,869 $341,000
Q4 2019

Feb 13, 2020
BUY
$1.42 - $2.17 $5,569 - $8,510
3,922 Added 1.47%
270,418 $397,000
Q3 2019

Nov 13, 2019
BUY
$1.75 - $2.47 $239,165 - $337,565
136,666 Added 105.27%
266,496 $557,000
Q2 2019

Aug 14, 2019
BUY
$1.79 - $2.61 $9,195 - $13,407
5,137 Added 4.12%
129,830 $316,000
Q1 2019

May 15, 2019
BUY
$2.42 - $3.83 $11,770 - $18,629
4,864 Added 4.06%
124,693 $326,000
Q4 2018

Feb 15, 2019
BUY
$2.46 - $3.87 $16,088 - $25,309
6,540 Added 5.77%
119,829 $361,000
Q2 2018

Aug 10, 2018
SELL
$2.99 - $4.99 $201,268 - $335,896
-67,314 Reduced 37.27%
113,289 $532,000
Q1 2018

May 17, 2018
SELL
$3.11 - $5.12 $89,906 - $148,014
-28,909 Reduced 13.8%
180,603 $572,000
Q4 2017

Feb 13, 2018
BUY
$4.61 - $7.04 $965,850 - $1.47 Million
209,512
209,512 $1.03 Million

Others Institutions Holding OPK

# of Institutions
246
Shares Held
207M
Call Options Held
1.49M
Put Options Held
332K
View Full List

About OPKO HEALTH, INC.

OPK Quotes by TradingView
  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.05B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email